{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:41:57Z","timestamp":1792651317379,"version":"4.5.0"},"reference-count":192,"publisher":"Elsevier","isbn-type":[{"value":"9780128244852","type":"print"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/bs.acr.2021.07.007","type":"book-chapter","created":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T05:52:48Z","timestamp":1643349168000},"page":"305-341","source":"Crossref","is-referenced-by-count":11,"title":["The RASopathies: Biology, genetics and therapeutic options"],"prefix":"10.1016","member":"78","reference":[{"issue":"11","key":"10.1016\/bs.acr.2021.07.007_bb0010","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1002\/ajmg.a.37259","article-title":"Craniosynostosis and Noonan syndrome with KRAS mutations: Expanding the phenotype with a case report and review of the literature","volume":"167A","author":"Addissie","year":"2015","journal-title":"American Journal of Medical Genetics. Part A"},{"issue":"2","key":"10.1016\/bs.acr.2021.07.007_bb0015","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.critrevonc.2012.11.001","article-title":"Neurofibromatosis type 1, gastrointestinal stromal tumor, leiomyosarcoma and osteosarcoma: Four cases of rare tumors and a review of the literature","volume":"86","author":"Afsar","year":"2013","journal-title":"Critical Reviews in Oncology\/Hematology"},{"issue":"8","key":"10.1016\/bs.acr.2021.07.007_bb0020","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1002\/ajmg.a.33518","article-title":"The face of Noonan syndrome: Does phenotype predict genotype","volume":"152A","author":"Allanson","year":"2010","journal-title":"American Journal of Medical Genetics. Part A"},{"issue":"11","key":"10.1016\/bs.acr.2021.07.007_bb0025","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1161\/CIRCULATIONAHA.116.026886","article-title":"Germline loss-of-function mutations in EPHB4 cause a second form of capillary malformation-arteriovenous malformation (CM-AVM2) deregulating RAS-MAPK signaling","volume":"136","author":"Amyere","year":"2017","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/bs.acr.2021.07.007_bb0030","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/cncr.22098","article-title":"Malignant peripheral nerve sheath tumors: Prognostic factors and survival in a series of patients treated at a single institution","volume":"107","author":"Anghileri","year":"2006","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/bs.acr.2021.07.007_bb0035","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1530\/EJE-11-0092","article-title":"Testicular size development and reproductive hormones in boys and adult males with Noonan syndrome: A longitudinal study","volume":"165","author":"Ankarberg-Lindgren","year":"2011","journal-title":"European Journal of Endocrinology"},{"issue":"1","key":"10.1016\/bs.acr.2021.07.007_bb0040","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ajhg.2013.05.021","article-title":"Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS\/MAPK pathway syndrome","volume":"93","author":"Aoki","year":"2013","journal-title":"American Journal of Human Genetics"},{"issue":"8","key":"10.1016\/bs.acr.2021.07.007_bb0045","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nm1084","article-title":"Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation","volume":"10","author":"Araki","year":"2004","journal-title":"Nature Medicine"},{"issue":"5","key":"10.1016\/bs.acr.2021.07.007_bb0050","doi-asserted-by":"crossref","first-page":"e1299","DOI":"10.1542\/peds.2013-3251","article-title":"Hemostatic abnormalities in Noonan syndrome","volume":"133","author":"Artoni","year":"2014","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/bs.acr.2021.07.007_bb0055","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0002-9394(00)00852-7","article-title":"Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: Relation to tumor location by magnetic resonance imaging","volume":"131","author":"Balcer","year":"2001","journal-title":"American Journal of Ophthalmology"},{"issue":"3","key":"10.1016\/bs.acr.2021.07.007_bb0060","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/ajmg.a.38086","article-title":"Constitutional bone impairment in Noonan syndrome","volume":"173","author":"Baldassarre","year":"2017","journal-title":"American Journal of Medical Genetics. Part A"},{"issue":"3","key":"10.1016\/bs.acr.2021.07.007_bb0065","first-page":"797","article-title":"Association of GIST and somatostatinoma in a patient with type-1 neurofibromatosis: Is there a common pathway?","volume":"104","author":"Barahona-Garrido","year":"2009","journal-title":"The American Journal of Gastroenterology"},{"issue":"6371","key":"10.1016\/bs.acr.2021.07.007_bb0070","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/356713a0","article-title":"Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients","volume":"356","author":"Basu","year":"1992","journal-title":"Nature"},{"issue":"9","key":"10.1016\/bs.acr.2021.07.007_bb0075","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1210\/jc.2006-0780","article-title":"Comprehensive mutation scanning of NF1 in apparently sporadic cases of pheochromocytoma","volume":"91","author":"Bausch","year":"2006","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"3","key":"10.1016\/bs.acr.2021.07.007_bb0080","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/ajmg.a.30813","article-title":"Neurofibromatosis-Noonan syndrome: Molecular evidence of the concurrence of both disorders in a patient","volume":"136","author":"Bertola","year":"2005","journal-title":"American Journal of Medical Genetics. Part A"},{"issue":"2","key":"10.1016\/bs.acr.2021.07.007_bb0085","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2214\/ajr.151.2.381","article-title":"Cranial MR imaging in neurofibromatosis","volume":"151","author":"Bognanno","year":"1988","journal-title":"AJR. American Journal of Roentgenology"},{"issue":"9","key":"10.1016\/bs.acr.2021.07.007_bb0090","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1242\/dev.106310","article-title":"Noonan and LEOPARD syndrome Shp2 variants induce heart displacement defects in zebrafish","volume":"141","author":"Bonetti","year":"2014","journal-title":"Development"},{"issue":"4","key":"10.1016\/bs.acr.2021.07.007_bb0095","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0033-8389(22)01039-9","article-title":"The central nervous system manifestations of the phakomatoses on MR","volume":"26","author":"Braffman","year":"1988","journal-title":"Radiologic Clinics of North America"},{"issue":"9","key":"10.1016\/bs.acr.2021.07.007_bb0100","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/ng2113","article-title":"Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype","volume":"39","author":"Brems","year":"2007","journal-title":"Nature Genetics"},{"issue":"18","key":"10.1016\/bs.acr.2021.07.007_bb0105","doi-asserted-by":"crossref","first-page":"7393","DOI":"10.1158\/0008-5472.CAN-09-1752","article-title":"Glomus tumors in neurofibromatosis type 1: Genetic, functional, and clinical evidence of a novel association","volume":"69","author":"Brems","year":"2009","journal-title":"Cancer Research"},{"issue":"11","key":"10.1016\/bs.acr.2021.07.007_bb0110","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/humu.22152","article-title":"Review and update of SPRED1 mutations causing Legius syndrome","volume":"33","author":"Brems","year":"2012","journal-title":"Human Mutation"},{"issue":"1","key":"10.1016\/bs.acr.2021.07.007_bb0115","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.brainresbull.2011.08.005","article-title":"Genetically engineered mouse models shed new light on the pathogenesis of neurofibromatosis type I-related neoplasms of the peripheral nervous system","volume":"88","author":"Brossier","year":"2012","journal-title":"Brain Research Bulletin"},{"issue":"6","key":"10.1016\/bs.acr.2021.07.007_bb0120","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/NEN.0000000000000201","article-title":"Classic ras proteins promote proliferation and survival via distinct phosphoproteome alterations in neurofibromin-null malignant peripheral nerve sheath tumor cells","volume":"74","author":"Brossier","year":"2015","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"2","key":"10.1016\/bs.acr.2021.07.007_bb0125","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/ajmg.a.36838","article-title":"Hydrops, fetal pleural effusions and chylothorax in three patients with CBL mutations","volume":"167A","author":"Bulow","year":"2015","journal-title":"American Journal of Medical Genetics. Part A"},{"issue":"7216","key":"10.1016\/bs.acr.2021.07.007_bb0130","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature07385","article-title":"Comprehensive genomic characterization defines human glioblastoma genes and core pathways","volume":"455","author":"Cancer Genome Atlas Research, N","year":"2008","journal-title":"Nature"},{"issue":"3","key":"10.1016\/bs.acr.2021.07.007_bb0135","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00401-011-0928-6","article-title":"Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms","volume":"123","author":"Carroll","year":"2012","journal-title":"Acta Neuropathologica"},{"issue":"14","key":"10.1016\/bs.acr.2021.07.007_bb0140","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/glia.20776","article-title":"How does the Schwann cell lineage form tumors in NF1?","volume":"56","author":"Carroll","year":"2008","journal-title":"Glia"},{"issue":"2","key":"10.1016\/bs.acr.2021.07.007_bb0145","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/ajmg.a.32488","article-title":"Cognitive profile of disorders associated with dysregulation of the RAS\/MAPK signaling cascade","volume":"149A","author":"Cesarini","year":"2009","journal-title":"American Journal of Medical Genetics. Part A"},{"issue":"5","key":"10.1016\/bs.acr.2021.07.007_bb0150","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1530\/EJE-15-0922","article-title":"Growth patterns of patients with Noonan syndrome: Correlation with age and genotype","volume":"174","author":"Cessans","year":"2016","journal-title":"European Journal of Endocrinology"},{"issue":"31","key":"10.1016\/bs.acr.2021.07.007_bb0155","doi-asserted-by":"crossref","first-page":"11473","DOI":"10.1073\/pnas.1324128111","article-title":"Next-generation sequencing identifies rare variants associated with Noonan syndrome","volume":"111","author":"Chen","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10.1016\/bs.acr.2021.07.007_bb0160","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ymgme.2012.04.003","article-title":"Decreased bone mineralization in children with Noonan syndrome: Another consequence of dysregulated RAS MAPKinase pathway?","volume":"106","author":"Choudhry","year":"2012","journal-title":"Molecular Genetics and Metabolism"},{"issue":"1","key":"10.1016\/bs.acr.2021.07.007_bb0165","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ng.497","article-title":"A restricted spectrum of NRAS mutations causes Noonan syndrome","volume":"42","author":"Cirstea","year":"2010","journal-title":"Nature Genetics"},{"issue":"3","key":"10.1016\/bs.acr.2021.07.007_bb0170","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/BF00303009","article-title":"Familial neurofibromatosis and juvenile chronic myelogenous leukemia","volume":"60","author":"Clark","year":"1982","journal-title":"Human Genetics"},{"issue":"4","key":"10.1016\/bs.acr.2021.07.007_bb0175","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/(SICI)1096-8628(19991203)87:4<317::AID-AJMG7>3.0.CO;2-X","article-title":"Neurofibromatosis type 1 growth charts","volume":"87","author":"Clementi","year":"1999","journal-title":"American Journal of Medical Genetics"},{"issue":"7","key":"10.1016\/bs.acr.2021.07.007_bb0180","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/jmg.34.7.582","article-title":"Multiple lentigines syndrome (LEOPARD syndrome or progressive cardiomyopathic lentiginosis)","volume":"34","author":"Coppin","year":"1997","journal-title":"Journal of Medical Genetics"},{"issue":"9","key":"10.1016\/bs.acr.2021.07.007_bb0185","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.425","article-title":"Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair","volume":"41","author":"Cordeddu","year":"2009","journal-title":"Nature Genetics"},{"issue":"11","key":"10.1016\/bs.acr.2021.07.007_bb0190","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1002\/humu.22834","article-title":"Activating mutations affecting the Dbl homology domain of SOS2 cause Noonan syndrome","volume":"36","author":"Cordeddu","year":"2015","journal-title":"Human Mutation"},{"issue":"2","key":"10.1016\/bs.acr.2021.07.007_bb0195","first-page":"114","article-title":"A new syndrome: Mental subnormality and nasal papillomata","volume":"13","author":"Costello","year":"1977","journal-title":"Australian Paediatric Journal"},{"issue":"10","key":"10.1016\/bs.acr.2021.07.007_bb0200","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/pbc.25556","article-title":"Rhabdomyosarcomas in children with neurofibromatosis type I: A national historical cohort","volume":"62","author":"Crucis","year":"2015","journal-title":"Pediatric Blood & Cancer"},{"issue":"5","key":"10.1016\/bs.acr.2021.07.007_bb0205","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/09297041003761985","article-title":"Cognitive profile of children with neurofibromatosis and reading disabilities","volume":"16","author":"Cutting","year":"2010","journal-title":"Child Neuropsychology"},{"issue":"6","key":"10.1016\/bs.acr.2021.07.007_bb0210","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1002\/ajmg.a.37639","article-title":"Nutritional aspects of Noonan syndrome and Noonan-related disorders","volume":"170","author":"da Silva","year":"2016","journal-title":"American Journal of Medical Genetics. Part A"},{"issue":"6","key":"10.1016\/bs.acr.2021.07.007_bb0215","first-page":"415","article-title":"Cerebrovascular stenosis in neurofibromatosis type 1 and utility of magnetic resonance angiography: Our experience and literature review","volume":"119","author":"D'Arco","year":"2014","journal-title":"La Radiologia Medica"},{"issue":"6","key":"10.1016\/bs.acr.2021.07.007_bb0220","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1086\/498454","article-title":"NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome","volume":"77","author":"De Luca","year":"2005","journal-title":"American Journal of Human Genetics"},{"issue":"1","key":"10.1016\/bs.acr.2021.07.007_bb0225","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/ajmg.1320410118","article-title":"Costello syndrome","volume":"41","author":"Der Kaloustian","year":"1991","journal-title":"American Journal of Medical Genetics"},{"issue":"3","key":"10.1016\/bs.acr.2021.07.007_bb0230","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1148\/radiology.195.3.7754001","article-title":"Neurofibromatosis type 1: Pathologic substrate of high-signal-intensity foci in the brain","volume":"195","author":"DiPaolo","year":"1995","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/bs.acr.2021.07.007_bb0235","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/hmg\/9.1.35","article-title":"NF1 microdeletion breakpoints are clustered at flanking repetitive sequences","volume":"9","author":"Dorschner","year":"2000","journal-title":"Human Molecular Genetics"},{"issue":"10","key":"10.1016\/bs.acr.2021.07.007_bb0240","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1002\/1097-0142(19860515)57:10<2006::AID-CNCR2820571022>3.0.CO;2-6","article-title":"Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases","volume":"57","author":"Ducatman","year":"1986","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/bs.acr.2021.07.007_bb0245","first-page":"305","article-title":"An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): Evidence for modifying genes","volume":"53","author":"Easton","year":"1993","journal-title":"American Journal of Human Genetics"},{"issue":"6","key":"10.1016\/bs.acr.2021.07.007_bb0250","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1086\/379793","article-title":"Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations","volume":"73","author":"Eerola","year":"2003","journal-title":"American Journal of Human Genetics"},{"issue":"3","key":"10.1016\/bs.acr.2021.07.007_bb0255","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1373\/clinchem.2010.153320","article-title":"Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma","volume":"57","author":"Eisenhofer","year":"2011","journal-title":"Clinical Chemistry"},{"issue":"10","key":"10.1016\/bs.acr.2021.07.007_bb0260","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/ajmg.a.33045","article-title":"Skeletal abnormalities in neurofibromatosis type 1: Approaches to therapeutic options","volume":"149A","author":"Elefteriou","year":"2009","journal-title":"American Journal of Medical Genetics. Part A"},{"issue":"22","key":"10.1016\/bs.acr.2021.07.007_bb0265","doi-asserted-by":"crossref","first-page":"15328","DOI":"10.1074\/jbc.M801382200","article-title":"Noonan syndrome-associated SHP-2\/Ptpn11 mutants enhance SIRPalpha and PZR tyrosyl phosphorylation and promote adhesion-mediated ERK activation","volume":"283","author":"Eminaga","year":"2008","journal-title":"The Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/bs.acr.2021.07.007_bb0270","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ajmg.a.31078","article-title":"HRAS mutations in Costello syndrome: Detection of constitutional activating mutations in codon 12 and 13 and loss of wild-type allele in malignancy","volume":"140","author":"Estep","year":"2006","journal-title":"American Journal of Medical Genetics. Part A"},{"issue":"5","key":"10.1016\/bs.acr.2021.07.007_bb0275","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/jmg.39.5.311","article-title":"Malignant peripheral nerve sheath tumours in neurofibromatosis 1","volume":"39","author":"Evans","year":"2002","journal-title":"Journal of Medical Genetics"},{"issue":"2","key":"10.1016\/bs.acr.2021.07.007_bb0280","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12094-013-1061-x","article-title":"Clinical and molecular prognostic predictors of malignant peripheral nerve sheath tumor","volume":"16","author":"Fan","year":"2014","journal-title":"Clinical & Translational Oncology"},{"issue":"2","key":"10.1016\/bs.acr.2021.07.007_bb0285","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/jmg.2006.045906","article-title":"Guidelines for the diagnosis and management of individuals with neurofibromatosis 1","volume":"44","author":"Ferner","year":"2007","journal-title":"Journal of Medical Genetics"},{"issue":"16","key":"10.1016\/bs.acr.2021.07.007_bb0290","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1093\/hmg\/ddu148","article-title":"Activating mutations in RRAS underlie a phenotype within the RASopathy spectrum and contribute to leukaemogenesis","volume":"23","author":"Flex","year":"2014","journal-title":"Human Molecular Genetics"},{"issue":"3","key":"10.1016\/bs.acr.2021.07.007_bb0295","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/humu.20005","article-title":"Noonan syndrome-associated SHP2\/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2\/MAPK1 activation","volume":"23","author":"Fragale","year":"2004","journal-title":"Human Mutation"},{"issue":"6","key":"10.1016\/bs.acr.2021.07.007_bb0300","doi-asserted-by":"crossref","first-page":"e1642","DOI":"10.1542\/peds.2013-1868","article-title":"Neurofibromatosis type 1 and autism spectrum disorder","volume":"132","author":"Garg","year":"2013","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/bs.acr.2021.07.007_bb0305","doi-asserted-by":"crossref","DOI":"10.1542\/peds.104.4.e49","article-title":"Neurofibromatosis bright objects in children with neurofibromatosis type 1: A proliferative potential?","volume":"104","author":"Griffiths","year":"1999","journal-title":"Pediatrics"},{"issue":"245","key":"10.1016\/bs.acr.2021.07.007_bb0310","first-page":"769","article-title":"Duodenal carcinoid tumours, phaeochromocytoma and neurofibromatosis: Islet cell tumour, phaeochromocytoma and the von Hippel-Lindau complex: Two distinctive neuroendocrine syndromes","volume":"64","author":"Griffiths","year":"1987","journal-title":"The Quarterly Journal of Medicine"},{"issue":"9","key":"10.1016\/bs.acr.2021.07.007_bb0315","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1002\/ajmg.a.37781","article-title":"A novel rasopathy caused by recurrent de novo missense mutations in PPP1CB closely resembles Noonan syndrome with loose anagen hair","volume":"170","author":"Gripp","year":"2016","journal-title":"American Journal of Medical Genetics. Part A"},{"issue":"20","key":"10.1016\/bs.acr.2021.07.007_bb0320","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/ajmg.a.31456","article-title":"Somatic mosaicism for an HRAS mutation causes Costello syndrome","volume":"140","author":"Gripp","year":"2006","journal-title":"American Journal of Medical Genetics. Part A"},{"issue":"10","key":"10.1016\/bs.acr.2021.07.007_bb0325","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1002\/ajmg.a.36098","article-title":"Expanding the SHOC2 mutation associated phenotype of Noonan syndrome with loose anagen hair: Structural brain anomalies and myelofibrosis","volume":"161A","author":"Gripp","year":"2013","journal-title":"American Journal of Medical Genetics. Part A"},{"issue":"4","key":"10.1016\/bs.acr.2021.07.007_bb0330","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1086\/301797","article-title":"Genetic linkage of hereditary gingival fibromatosis to chromosome 2p21","volume":"62","author":"Hart","year":"1998","journal-title":"American Journal of Human Genetics"},{"issue":"4","key":"10.1016\/bs.acr.2021.07.007_bb0335","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1086\/339689","article-title":"A mutation in the SOS1 gene causes hereditary gingival fibromatosis type 1","volume":"70","author":"Hart","year":"2002","journal-title":"American Journal of Human Genetics"},{"issue":"5","key":"10.1016\/bs.acr.2021.07.007_bb0340","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.91225","article-title":"Elucidation of MRAS-mediated Noonan syndrome with cardiac hypertrophy","volume":"2","author":"Higgins","year":"2017","journal-title":"JCI Insight"},{"issue":"24","key":"10.1016\/bs.acr.2021.07.007_bb0345","doi-asserted-by":"crossref","first-page":"6553","DOI":"10.1093\/hmg\/ddu376","article-title":"New BRAF knockin mice provide a pathogenetic mechanism of developmental defects and a therapeutic approach in cardio-facio-cutaneous syndrome","volume":"23","author":"Inoue","year":"2014","journal-title":"Human Molecular Genetics"},{"issue":"8","key":"10.1016\/bs.acr.2021.07.007_bb0350","first-page":"1513","article-title":"Neurofibromatosis type 1: The evolution of deep gray and white matter MR abnormalities","volume":"15","author":"Itoh","year":"1994","journal-title":"AJNR. American Journal of Neuroradiology"},{"issue":"6258","key":"10.1016\/bs.acr.2021.07.007_bb0355","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/343558a0","article-title":"Paternal origin of new mutations in von Recklinghausen neurofibromatosis","volume":"343","author":"Jadayel","year":"1990","journal-title":"Nature"},{"issue":"28","key":"10.1016\/bs.acr.2021.07.007_bb0360","doi-asserted-by":"crossref","first-page":"20245","DOI":"10.1074\/jbc.M701609200","article-title":"Germ line gain of function with SOS1 mutation in hereditary gingival fibromatosis","volume":"282","author":"Jang","year":"2007","journal-title":"The Journal of Biological Chemistry"},{"issue":"3","key":"10.1016\/bs.acr.2021.07.007_bb0365","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1086\/323043","article-title":"Molecular characterization and gene content of breakpoint boundaries in patients with neurofibromatosis type 1 with 17q11.2 microdeletions","volume":"69","author":"Jenne","year":"2001","journal-title":"American Journal of Human Genetics"},{"issue":"1","key":"10.1016\/bs.acr.2021.07.007_bb0370","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1172\/JCI60578","article-title":"MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors","volume":"123","author":"Jessen","year":"2013","journal-title":"The Journal of Clinical Investigation"},{"issue":"5","key":"10.1016\/bs.acr.2021.07.007_bb0375","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1158\/1535-7163.MCT-07-2335","article-title":"Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors","volume":"7","author":"Johansson","year":"2008","journal-title":"Molecular Cancer Therapeutics"},{"issue":"10","key":"10.1016\/bs.acr.2021.07.007_bb0380","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/gim.2017.249","article-title":"Autosomal recessive Noonan syndrome associated with biallelic LZTR1 variants","volume":"20","author":"Johnston","year":"2018","journal-title":"Genetics in Medicine"},{"issue":"8","key":"10.1016\/bs.acr.2021.07.007_bb0385","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/ejhg.2011.37","article-title":"Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation","volume":"19","author":"Jongmans","year":"2011","journal-title":"European Journal of Human Genetics"},{"issue":"6","key":"10.1016\/bs.acr.2021.07.007_bb0390","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1172\/JCI67084","article-title":"RASA1 functions in EPHB4 signaling pathway to suppress endothelial mTORC1 activity","volume":"124","author":"Kawasaki","year":"2014","journal-title":"The Journal of Clinical Investigation"},{"issue":"3","key":"10.1016\/bs.acr.2021.07.007_bb0395","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1086\/423624","article-title":"High frequency of mosaicism among patients with neurofibromatosis type 1 (NF1) with microdeletions caused by somatic recombination of the JJAZ1 gene","volume":"75","author":"Kehrer-Sawatzki","year":"2004","journal-title":"American Journal of Human Genetics"},{"issue":"5","key":"10.1016\/bs.acr.2021.07.007_bb0400","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/jmg.2005.040352","article-title":"Genotype-phenotype correlation in Costello syndrome: HRAS mutation analysis in 43 cases","volume":"43","author":"Kerr","year":"2006","journal-title":"Journal of Medical Genetics"},{"issue":"3","key":"10.1016\/bs.acr.2021.07.007_bb0405","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/pbc.24281","article-title":"Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas","volume":"60","author":"Kim","year":"2013","journal-title":"Pediatric Blood & Cancer"},{"issue":"10","key":"10.1016\/bs.acr.2021.07.007_bb0410","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1074\/jbc.M513068200","article-title":"PTPN11 (Shp2) mutations in LEOPARD syndrome have dominant negative, not activating, effects","volume":"281","author":"Kontaridis","year":"2006","journal-title":"The Journal of Biological Chemistry"},{"issue":"5","key":"10.1016\/bs.acr.2021.07.007_bb0415","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ejmg.2009.04.006","article-title":"Novel BRAF mutation in a patient with LEOPARD syndrome and normal intelligence","volume":"52","author":"Koudova","year":"2009","journal-title":"European Journal of Medical Genetics"},{"issue":"8","key":"10.1016\/bs.acr.2021.07.007_bb0420","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/bjc.2015.75","article-title":"Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromes","volume":"112","author":"Kratz","year":"2015","journal-title":"British Journal of Cancer"},{"issue":"8","key":"10.1016\/bs.acr.2021.07.007_bb0425","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1161\/01.RES.0000186194.06514.b0","article-title":"Noonan syndrome mutation Q79R in Shp2 increases proliferation of valve primordia mesenchymal cells via extracellular signal-regulated kinase 1\/2 signaling","volume":"97","author":"Krenz","year":"2005","journal-title":"Circulation Research"},{"issue":"10","key":"10.1016\/bs.acr.2021.07.007_bb0430","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/jmg.2006.041095","article-title":"Vitamin D deficiency associated with number of neurofibromas in neurofibromatosis 1","volume":"43","author":"Lammert","year":"2006","journal-title":"Journal of Medical Genetics"},{"issue":"1","key":"10.1016\/bs.acr.2021.07.007_bb0435","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejmg.2017.10.004","article-title":"Somatic second hit mutation of RASA1 in vascular endothelial cells in capillary malformation-arteriovenous malformation","volume":"61","author":"Lapinski","year":"2018","journal-title":"European Journal of Medical Genetics"},{"issue":"1","key":"10.1016\/bs.acr.2021.07.007_bb0440","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1399-0004.2010.01618.x","article-title":"Identification of five novel SPRED1 germline mutations in Legius syndrome","volume":"80","author":"Laycock-van Spyk","year":"2011","journal-title":"Clinical Genetics"},{"key":"10.1016\/bs.acr.2021.07.007_bb0445","doi-asserted-by":"crossref","DOI":"10.1038\/s41436-021-01170-5","article-title":"Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: An international consensus recommendation","author":"Legius","year":"2021","journal-title":"Genetics in Medicine"},{"issue":"7","key":"10.1016\/bs.acr.2021.07.007_bb0450","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/humu.21492","article-title":"SOS1 mutations in Noonan syndrome: Molecular spectrum, structural insights on pathogenic effects, and genotype-phenotype correlations","volume":"32","author":"Lepri","year":"2011","journal-title":"Human Mutation"},{"issue":"2","key":"10.1016\/bs.acr.2021.07.007_bb0455","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/1096-8628(20001113)95:2<108::AID-AJMG4>3.0.CO;2-0","article-title":"Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1","volume":"95","author":"Lin","year":"2000","journal-title":"American Journal of Medical Genetics"},{"issue":"1","key":"10.1016\/bs.acr.2021.07.007_bb0460","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0022-3476(94)70122-9","article-title":"Natural history of optic pathway tumors in children with neurofibromatosis type 1: A longitudinal study","volume":"125","author":"Listernick","year":"1994","journal-title":"The Journal of Pediatrics"},{"issue":"5","key":"10.1016\/bs.acr.2021.07.007_bb0465","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0022-3476(95)70159-1","article-title":"Optic pathway tumors in children: The effect of neurofibromatosis type 1 on clinical manifestations and natural history","volume":"127","author":"Listernick","year":"1995","journal-title":"The Journal of Pediatrics"},{"issue":"5","key":"10.1016\/bs.acr.2021.07.007_bb0470","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/PAP.0000000000000197","article-title":"Recent advances in the diagnosis and pathogenesis of neurofibromatosis type 1 (NF1)-associated peripheral nervous system neoplasms","volume":"25","author":"Longo","year":"2018","journal-title":"Advances in Anatomic Pathology"},{"issue":"13","key":"10.1016\/bs.acr.2021.07.007_bb0475","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/hmg\/10.13.1387","article-title":"Recombination hotspot in NF1 microdeletion patients","volume":"10","author":"Lopez-Correa","year":"2001","journal-title":"Human Molecular Genetics"},{"issue":"12","key":"10.1016\/bs.acr.2021.07.007_bb0480","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1016\/j.ajpath.2014.08.018","article-title":"Blood vascular abnormalities in Rasa1(R780Q) knockin mice: Implications for the pathogenesis of capillary malformation-arteriovenous malformation","volume":"184","author":"Lubeck","year":"2014","journal-title":"The American Journal of Pathology"},{"issue":"12","key":"10.1016\/bs.acr.2021.07.007_bb0485","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s00439-016-1731-1","article-title":"De novo missense variants in PPP1CB are associated with intellectual disability and congenital heart disease","volume":"135","author":"Ma","year":"2016","journal-title":"Human Genetics"},{"issue":"19","key":"10.1016\/bs.acr.2021.07.007_bb0490","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1200\/JCO.2008.20.4495","article-title":"Phase II study of sorafenib in patients with metastatic or recurrent sarcomas","volume":"27","author":"Maki","year":"2009","journal-title":"Journal of Clinical Oncology"},{"issue":"11","key":"10.1016\/bs.acr.2021.07.007_bb0495","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1002\/ajmg.a.35519","article-title":"Growth standards of patients with Noonan and Noonan-like syndromes with mutations in the RAS\/MAPK pathway","volume":"158A","author":"Malaquias","year":"2012","journal-title":"American Journal of Medical Genetics. Part A"},{"issue":"5","key":"10.1016\/bs.acr.2021.07.007_bb0500","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1210\/jc.2008-2419","article-title":"Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and\/or functional or nonfunctional paragangliomas","volume":"94","author":"Mannelli","year":"2009","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"2","key":"10.1016\/bs.acr.2021.07.007_bb0505","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ajhg.2010.06.015","article-title":"Heterozygous germline mutations in the CBL tumor-suppressor gene cause a Noonan syndrome-like phenotype","volume":"87","author":"Martinelli","year":"2010","journal-title":"American Journal of Human Genetics"},{"issue":"8","key":"10.1016\/bs.acr.2021.07.007_bb0510","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/humu.22809","article-title":"Molecular diversity and associated phenotypic spectrum of germline CBL mutations","volume":"36","author":"Martinelli","year":"2015","journal-title":"Human Mutation"},{"issue":"3","key":"10.1016\/bs.acr.2021.07.007_bb0515","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/ajmg.a.10923","article-title":"Noonan-like syndrome with loose anagen hair: A new syndrome?","volume":"118A","author":"Mazzanti","year":"2003","journal-title":"American Journal of Medical Genetics. Part A"},{"issue":"7","key":"10.1016\/bs.acr.2021.07.007_bb0520","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/jmg.2006.048140","article-title":"Further evidence of the increased risk for malignant peripheral nerve sheath tumour from a Scottish cohort of patients with neurofibromatosis type 1","volume":"44","author":"McCaughan","year":"2007","journal-title":"Journal of Medical Genetics"},{"issue":"3","key":"10.1016\/bs.acr.2021.07.007_bb0525","first-page":"197","article-title":"A clinical study of type 1 neurofibromatosis in north west England","volume":"36","author":"McGaughran","year":"1999","journal-title":"Journal of Medical Genetics"},{"issue":"6","key":"10.1016\/bs.acr.2021.07.007_bb0530","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/1098-1004(200006)15:6<541::AID-HUMU6>3.0.CO;2-N","article-title":"Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects","volume":"15","author":"Messiaen","year":"2000","journal-title":"Human Mutation"},{"issue":"1","key":"10.1016\/bs.acr.2021.07.007_bb0535","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/01.pas.0000176433.81079.bd","article-title":"Gastrointestinal stromal tumors in patients with neurofibromatosis 1: A clinicopathologic and molecular genetic study of 45 cases","volume":"30","author":"Miettinen","year":"2006","journal-title":"The American Journal of Surgical Pathology"},{"issue":"37","key":"10.1016\/bs.acr.2021.07.007_bb0540","first-page":"E3929","article-title":"C-terminal domain small phosphatase 1 and MAP kinase reciprocally control REST stability and neuronal differentiation","volume":"111","author":"Nesti","year":"2014","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"10.1016\/bs.acr.2021.07.007_bb966","first-page":"575","article-title":"National Institutes of Health consensus development conference","volume":"45","year":"1988","journal-title":"Archives of Neurology"},{"issue":"9","key":"10.1016\/bs.acr.2021.07.007_bb0545","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/ng.641","article-title":"Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia","volume":"42","author":"Niemeyer","year":"2010","journal-title":"Nature Genetics"},{"issue":"3","key":"10.1016\/bs.acr.2021.07.007_bb0550","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/ng1749","article-title":"Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome","volume":"38","author":"Niihori","year":"2006","journal-title":"Nature Genetics"},{"issue":"4","key":"10.1016\/bs.acr.2021.07.007_bb0555","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1001\/archpedi.1968.02100020377005","article-title":"Hypertelorism with Turner phenotype. A new syndrome with associated congenital heart disease","volume":"116","author":"Noonan","year":"1968","journal-title":"American Journal of Diseases of Children"},{"issue":"3","key":"10.1016\/bs.acr.2021.07.007_bb0560","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000369012","article-title":"The efficacy and safety of growth hormone therapy in children with noonan syndrome: A review of the evidence","volume":"83","author":"Noonan","year":"2015","journal-title":"Hormone Research in P\u00e6diatrics"},{"issue":"6","key":"10.1016\/bs.acr.2021.07.007_bb0565","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1399-0004.2009.01233.x","article-title":"Noonan syndrome and neurofibromatosis type I in a family with a novel mutation in NF1","volume":"76","author":"Nystrom","year":"2009","journal-title":"Clinical Genetics"},{"issue":"3","key":"10.1016\/bs.acr.2021.07.007_bb0570","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jvs.2007.03.055","article-title":"Vascular abnormalities in patients with neurofibromatosis syndrome type I: Clinical spectrum, management, and results","volume":"46","author":"Oderich","year":"2007","journal-title":"Journal of Vascular Surgery"},{"issue":"26","key":"10.1016\/bs.acr.2021.07.007_bb0575","doi-asserted-by":"crossref","first-page":"20020","DOI":"10.1074\/jbc.M000981200","article-title":"Regulatory proteins of R-Ras, TC21\/R-Ras2, and M-Ras\/R-Ras3","volume":"275","author":"Ohba","year":"2000","journal-title":"The Journal of Biological Chemistry"},{"issue":"4","key":"10.1016\/bs.acr.2021.07.007_bb0580","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/hmg\/ddi471","article-title":"Transgenic Drosophila models of Noonan syndrome causing PTPN11 gain-of-function mutations","volume":"15","author":"Oishi","year":"2006","journal-title":"Human Molecular Genetics"},{"issue":"1","key":"10.1016\/bs.acr.2021.07.007_bb0585","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/hmg\/ddn336","article-title":"Phosphatase-defective LEOPARD syndrome mutations in PTPN11 gene have gain-of-function effects during Drosophila development","volume":"18","author":"Oishi","year":"2009","journal-title":"Human Molecular Genetics"},{"issue":"8","key":"10.1016\/bs.acr.2021.07.007_bb0590","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/ng2073","article-title":"Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy","volume":"39","author":"Pandit","year":"2007","journal-title":"Nature Genetics"},{"issue":"5","key":"10.1016\/bs.acr.2021.07.007_bb0595","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/ejhg.2014.145","article-title":"Neurofibromatosis type 1 molecular diagnosis: What can NGS do for you when you have a large gene with loss of function mutations?","volume":"23","author":"Pasmant","year":"2015","journal-title":"European Journal of Human Genetics"},{"issue":"7","key":"10.1016\/bs.acr.2021.07.007_bb0600","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/jmg.2008.065243","article-title":"SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype","volume":"46","author":"Pasmant","year":"2009","journal-title":"Journal of Medical Genetics"},{"issue":"6","key":"10.1016\/bs.acr.2021.07.007_bb0605","doi-asserted-by":"crossref","first-page":"E1506","DOI":"10.1002\/humu.21271","article-title":"NF1 microdeletions in neurofibromatosis type 1: From genotype to phenotype","volume":"31","author":"Pasmant","year":"2010","journal-title":"Human Mutation"},{"issue":"1","key":"10.1016\/bs.acr.2021.07.007_bb0610","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1634\/theoncologist.2010-0181","article-title":"Neoplasms associated with germline and somatic NF1 gene mutations","volume":"17","author":"Patil","year":"2012","journal-title":"The Oncologist"},{"issue":"10","key":"10.1016\/bs.acr.2021.07.007_bb0615","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/jmg.2010.076836","article-title":"Germline mutations of the CBL gene define a new genetic syndrome with predisposition to juvenile myelomonocytic leukaemia","volume":"47","author":"Perez","year":"2010","journal-title":"Journal of Medical Genetics"},{"issue":"4","key":"10.1016\/bs.acr.2021.07.007_bb0620","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/dmcn.12621","article-title":"Attention skills and executive functioning in children with Noonan syndrome and their unaffected siblings","volume":"57","author":"Pierpont","year":"2015","journal-title":"Developmental Medicine and Child Neurology"},{"key":"10.1016\/bs.acr.2021.07.007_bb0625","doi-asserted-by":"crossref","first-page":"756395","DOI":"10.1155\/2009\/756395","article-title":"Survival in malignant peripheral nerve sheath tumours: A comparison between sporadic and neurofibromatosis type 1-associated tumours","volume":"2009","author":"Porter","year":"2009","journal-title":"Sarcoma"},{"issue":"7","key":"10.1016\/bs.acr.2021.07.007_bb0630","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/archdischild-2013-305047","article-title":"Cardiovascular disease in Noonan syndrome","volume":"99","author":"Prendiville","year":"2014","journal-title":"Archives of Disease in Childhood"},{"issue":"12","key":"10.1016\/bs.acr.2021.07.007_bb0635","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/ng1920","article-title":"Conservation of hotspots for recombination in low-copy repeats associated with the NF1 microdeletion","volume":"38","author":"Raedt","year":"2006","journal-title":"Nature Genetics"},{"issue":"3","key":"10.1016\/bs.acr.2021.07.007_bb0640","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/BF00441408","article-title":"Noonan syndrome: Growth and clinical manifestations in 144 cases","volume":"148","author":"Ranke","year":"1988","journal-title":"European Journal of Pediatrics"},{"issue":"5","key":"10.1016\/bs.acr.2021.07.007_bb0645","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1086\/320121","article-title":"Mortality in neurofibromatosis 1: An analysis using U.S. death certificates","volume":"68","author":"Rasmussen","year":"2001","journal-title":"American Journal of Human Genetics"},{"issue":"2","key":"10.1016\/bs.acr.2021.07.007_bb0650","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ajmg.c.30294","article-title":"Costello and cardio-facio-cutaneous syndromes: Moving toward clinical trials in RASopathies","volume":"157C","author":"Rauen","year":"2011","journal-title":"American Journal of Medical Genetics. Part C, Seminars in Medical Genetics"},{"issue":"3","key":"10.1016\/bs.acr.2021.07.007_bb0655","doi-asserted-by":"crossref","first-page":"e476","DOI":"10.1542\/peds.2009-0152","article-title":"Cerebral arteriopathy in children with neurofibromatosis type 1","volume":"124","author":"Rea","year":"2009","journal-title":"Pediatrics"},{"issue":"18","key":"10.1016\/bs.acr.2021.07.007_bb0660","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJM199105023241812","article-title":"Neurofibromatosis: Past, present, and future","volume":"324","author":"Riccardi","year":"1991","journal-title":"The New England Journal of Medicine"},{"issue":"11","key":"10.1016\/bs.acr.2021.07.007_bb0665","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1136\/jmg.2006.042796","article-title":"The cardiofaciocutaneous syndrome","volume":"43","author":"Roberts","year":"2006","journal-title":"Journal of Medical Genetics"},{"issue":"4","key":"10.1016\/bs.acr.2021.07.007_bb0670","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.thorsurg.2010.07.007","article-title":"Pectus carinatum","volume":"20","author":"Robicsek","year":"2010","journal-title":"Thoracic Surgery Clinics"},{"issue":"3","key":"10.1016\/bs.acr.2021.07.007_bb0675","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/NEN.0b013e318165eb75","article-title":"Gliomas in neurofibromatosis type 1: A clinicopathologic study of 100 patients","volume":"67","author":"Rodriguez","year":"2008","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"issue":"5765","key":"10.1016\/bs.acr.2021.07.007_bb0680","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1126\/science.1124642","article-title":"Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome","volume":"311","author":"Rodriguez-Viciana","year":"2006","journal-title":"Science"},{"issue":"7","key":"10.1016\/bs.acr.2021.07.007_bb0685","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.479","article-title":"Intellectual development in Noonan syndrome: A longitudinal study","volume":"6","author":"Roelofs","year":"2016","journal-title":"Brain and Behavior: A Cognitive Neuroscience Perspective"},{"issue":"11","key":"10.1016\/bs.acr.2021.07.007_bb0690","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/humu.22832","article-title":"High incidence of Noonan syndrome features including short stature and pulmonic stenosis in patients carrying NF1 missense mutations affecting p.Arg1809: Genotype-phenotype correlation","volume":"36","author":"Rojnueangnit","year":"2015","journal-title":"Human Mutation"},{"issue":"4","key":"10.1016\/bs.acr.2021.07.007_bb0695","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1542\/peds.2009-3207","article-title":"Noonan syndrome: Clinical features, diagnosis, and management guidelines","volume":"126","author":"Romano","year":"2010","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/bs.acr.2021.07.007_bb0700","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1210\/jc.2008-2094","article-title":"Growth response, near-adult height, and patterns of growth and puberty in patients with noonan syndrome treated with growth hormone","volume":"94","author":"Romano","year":"2009","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"4","key":"10.1016\/bs.acr.2021.07.007_bb0705","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/humu.20955","article-title":"Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: Molecular diversity and associated phenotypic spectrum","volume":"30","author":"Sarkozy","year":"2009","journal-title":"Human Mutation"},{"issue":"22","key":"10.1016\/bs.acr.2021.07.007_bb0710","doi-asserted-by":"crossref","first-page":"7765","DOI":"10.1128\/MCB.00965-07","article-title":"Biochemical and functional characterization of germ line KRAS mutations","volume":"27","author":"Schubbert","year":"2007","journal-title":"Molecular and Cellular Biology"},{"issue":"10","key":"10.1016\/bs.acr.2021.07.007_bb0715","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1586\/14737175.2014.953931","article-title":"Cognitive and behavioral problems in children with neurofibromatosis type 1: Challenges and future directions","volume":"14","author":"Schwetye","year":"2014","journal-title":"Expert Review of Neurotherapeutics"},{"issue":"2","key":"10.1016\/bs.acr.2021.07.007_bb0720","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/adc.67.2.178","article-title":"A clinical study of Noonan syndrome","volume":"67","author":"Sharland","year":"1992","journal-title":"Archives of Disease in Childhood"},{"issue":"2","key":"10.1016\/bs.acr.2021.07.007_bb0725","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/adc.2006.104547","article-title":"The natural history of Noonan syndrome: A long-term follow-up study","volume":"92","author":"Shaw","year":"2007","journal-title":"Archives of Disease in Childhood"},{"issue":"1","key":"10.1016\/bs.acr.2021.07.007_bb0730","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/jmg.33.1.2","article-title":"Molecular genetics of neurofibromatosis type 1 (NF1)","volume":"33","author":"Shen","year":"1996","journal-title":"Journal of Medical Genetics"},{"issue":"39","key":"10.1016\/bs.acr.2021.07.007_bb0735","doi-asserted-by":"crossref","first-page":"30740","DOI":"10.1074\/jbc.M001702200","article-title":"Single cell Ras-GTP analysis reveals altered Ras activity in a subpopulation of neurofibroma Schwann cells but not fibroblasts","volume":"275","author":"Sherman","year":"2000","journal-title":"The Journal of Biological Chemistry"},{"issue":"2","key":"10.1016\/bs.acr.2021.07.007_bb0740","first-page":"725","article-title":"The phakomatoses","volume":"13","author":"Smirniotopoulos","year":"1992","journal-title":"AJNR. American Journal of Neuroradiology"},{"issue":"6","key":"10.1016\/bs.acr.2021.07.007_bb0745","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/ajmg.a.33894","article-title":"Identification of SPRED1 deletions using RT-PCR, multiplex ligation-dependent probe amplification and quantitative PCR","volume":"155A","author":"Spencer","year":"2011","journal-title":"American Journal of Medical Genetics. Part A"},{"issue":"7","key":"10.1016\/bs.acr.2021.07.007_bb0750","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1136\/jmg.2008.065474","article-title":"SPRED1 mutations (Legius syndrome): Another clinically useful genotype for dissecting the neurofibromatosis type 1 phenotype","volume":"46","author":"Spurlock","year":"2009","journal-title":"Journal of Medical Genetics"},{"issue":"6","key":"10.1016\/bs.acr.2021.07.007_bb0755","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1399-0004.2011.01754.x","article-title":"Two novel germline KRAS mutations: Expanding the molecular and clinical phenotype","volume":"81","author":"Stark","year":"2012","journal-title":"Clinical Genetics"},{"issue":"6","key":"10.1016\/bs.acr.2021.07.007_bb0760","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1086\/522089","article-title":"Type 2 NF1 deletions are highly unusual by virtue of the absence of nonallelic homologous recombination hotspots and an apparent preference for female mitotic recombination","volume":"81","author":"Steinmann","year":"2007","journal-title":"American Journal of Human Genetics"},{"issue":"3","key":"10.1016\/bs.acr.2021.07.007_bb0765","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1399-0004.2006.00576.x","article-title":"Clinical and molecular aspects of an informative family with neurofibromatosis type 1 and Noonan phenotype","volume":"69","author":"Stevenson","year":"2006","journal-title":"Clinical Genetics"},{"issue":"5","key":"10.1016\/bs.acr.2021.07.007_bb0770","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.devcel.2010.03.009","article-title":"Phosphatase-dependent and -independent functions of Shp2 in neural crest cells underlie LEOPARD syndrome pathogenesis","volume":"18","author":"Stewart","year":"2010","journal-title":"Developmental Cell"},{"issue":"5","key":"10.1016\/bs.acr.2021.07.007_bb0775","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/bjc.1994.431","article-title":"Neurofibromatosis and childhood leukaemia\/lymphoma: A population-based UKCCSG study","volume":"70","author":"Stiller","year":"1994","journal-title":"British Journal of Cancer"},{"issue":"10","key":"10.1016\/bs.acr.2021.07.007_bb0780","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/jmedgenet-2014-102611","article-title":"Juvenile myelomonocytic leukaemia and Noonan syndrome","volume":"51","author":"Strullu","year":"2014","journal-title":"Journal of Medical Genetics"},{"issue":"3","key":"10.1016\/bs.acr.2021.07.007_bb0785","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1245\/s10434-011-1978-7","article-title":"Malignant peripheral nerve sheath tumors (MPNST): The Mayo Clinic experience","volume":"19","author":"Stucky","year":"2012","journal-title":"Annals of Surgical Oncology"},{"issue":"1","key":"10.1016\/bs.acr.2021.07.007_bb0790","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/jcp.20694","article-title":"The Cbl family proteins: Ring leaders in regulation of cell signaling","volume":"209","author":"Swaminathan","year":"2006","journal-title":"Journal of Cellular Physiology"},{"issue":"4","key":"10.1016\/bs.acr.2021.07.007_bb0795","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1365-2265.1988.tb03666.x","article-title":"Neurofibromatosis associated with somatostatinoma: A report of two patients","volume":"28","author":"Swinburn","year":"1988","journal-title":"Clinical Endocrinology"},{"issue":"3","key":"10.1016\/bs.acr.2021.07.007_bb0800","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/(SICI)1096-8628(20000529)92:3<224::AID-AJMG12>3.0.CO;2-J","article-title":"Growth charts for young children with neurofibromatosis 1 (NF1)","volume":"92","author":"Szudek","year":"2000","journal-title":"American Journal of Medical Genetics"},{"issue":"12","key":"10.1016\/bs.acr.2021.07.007_bb0805","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1136\/jmg.37.12.933","article-title":"Growth in North American white children with neurofibromatosis 1 (NF1)","volume":"37","author":"Szudek","year":"2000","journal-title":"Journal of Medical Genetics"},{"issue":"5","key":"10.1016\/bs.acr.2021.07.007_bb0810","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1210\/er.2017-00232","article-title":"The RASopathy family: Consequences of germline activation of the RAS\/MAPK pathway","volume":"39","author":"Tajan","year":"2018","journal-title":"Endocrine Reviews"},{"issue":"2","key":"10.1016\/bs.acr.2021.07.007_bb0815","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1086\/499925","article-title":"Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease","volume":"78","author":"Tartaglia","year":"2006","journal-title":"American Journal of Human Genetics"},{"issue":"4","key":"10.1016\/bs.acr.2021.07.007_bb0820","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ng772","article-title":"Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome","volume":"29","author":"Tartaglia","year":"2001","journal-title":"Nature Genetics"},{"issue":"3","key":"10.1016\/bs.acr.2021.07.007_bb0825","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ophtha.2003.06.008","article-title":"Neurofibromatosis type 1 and optic pathway gliomas: Follow-up of 54 patients","volume":"111","author":"Thiagalingam","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/bs.acr.2021.07.007_bb0830","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3389\/fped.2017.00227","article-title":"Cognitive and behavioral disorders in children with neurofibromatosis type 1","volume":"5","author":"Torres Nupan","year":"2017","journal-title":"Frontiers in Pediatrics"},{"issue":"4","key":"10.1016\/bs.acr.2021.07.007_bb0835","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1159\/000247806","article-title":"Loose anagen hair in a child with Noonan's syndrome","volume":"182","author":"Tosti","year":"1991","journal-title":"Dermatologica"},{"issue":"9","key":"10.1016\/bs.acr.2021.07.007_bb0840","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1001\/archderm.1997.03890450033004","article-title":"Loose anagen hair","volume":"133","author":"Tosti","year":"1997","journal-title":"Archives of Dermatology"},{"issue":"1","key":"10.1016\/bs.acr.2021.07.007_bb0845","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00439-018-1951-7","article-title":"Delineation of LZTR1 mutation-positive patients with Noonan syndrome and identification of LZTR1 binding to RAF1-PPP1CB complexes","volume":"138","author":"Umeki","year":"2019","journal-title":"Human Genetics"},{"issue":"2","key":"10.1016\/bs.acr.2021.07.007_bb0850","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/bjc.2016.403","article-title":"Breast cancer in neurofibromatosis type 1: Overrepresentation of unfavourable prognostic factors","volume":"116","author":"Uusitalo","year":"2017","journal-title":"British Journal of Cancer"},{"key":"10.1016\/bs.acr.2021.07.007_bb0855","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejca.2015.12.015","article-title":"Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO)","volume":"56","author":"Valentin","year":"2016","journal-title":"European Journal of Cancer"},{"issue":"7","key":"10.1016\/bs.acr.2021.07.007_bb0860","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/BF01377205","article-title":"MRI findings in children with neurofibromatosis type 1: A prospective study","volume":"26","author":"Van Es","year":"1996","journal-title":"Pediatric Radiology"},{"issue":"1","key":"10.1016\/bs.acr.2021.07.007_bb0865","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0092-8674(90)90252-A","article-title":"Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus","volume":"62","author":"Viskochil","year":"1990","journal-title":"Cell"},{"issue":"6847","key":"10.1016\/bs.acr.2021.07.007_bb0870","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/35088082","article-title":"Spred is a Sprouty-related suppressor of Ras signalling","volume":"412","author":"Wakioka","year":"2001","journal-title":"Nature"},{"issue":"4965","key":"10.1016\/bs.acr.2021.07.007_bb0875","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1126\/science.2134734","article-title":"Type 1 neurofibromatosis gene: Identification of a large transcript disrupted in three NF1 patients","volume":"249","author":"Wallace","year":"1990","journal-title":"Science"},{"issue":"5","key":"10.1016\/bs.acr.2021.07.007_bb0880","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0022-5347(05)68171-2","article-title":"von Recklinghausen's disease and pheochromocytomas","volume":"162","author":"Walther","year":"1999","journal-title":"The Journal of Urology"},{"issue":"1","key":"10.1016\/bs.acr.2021.07.007_bb0885","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/gcc.22503","article-title":"Breast cancer risk and germline genomic profiling of women with neurofibromatosis type 1 who developed breast cancer","volume":"57","author":"Wang","year":"2018","journal-title":"Genes, Chromosomes & Cancer"},{"issue":"1","key":"10.1016\/bs.acr.2021.07.007_bb0890","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3171\/2015.12.JNS152443","article-title":"Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors","volume":"126","author":"Watson","year":"2017","journal-title":"Journal of Neurosurgery"},{"key":"10.1016\/bs.acr.2021.07.007_bb0895","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpath.2021.05.008","article-title":"The role of R-Ras proteins in normal and pathologic migration and morphologic change","author":"Weber","year":"2021","journal-title":"The American Journal of Pathology"},{"issue":"5","key":"10.1016\/bs.acr.2021.07.007_bb0900","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/neuonc\/nou004","article-title":"Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas","volume":"16","author":"Widemann","year":"2014","journal-title":"Neuro-Oncology"},{"issue":"3","key":"10.1016\/bs.acr.2021.07.007_bb0905","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1200\/JCO.2005.03.8638","article-title":"Phase I trial and pharmacokinetic study of the farnesyltransferase inhibitor tipifarnib in children with refractory solid tumors or neurofibromatosis type I and plexiform neurofibromas","volume":"24","author":"Widemann","year":"2006","journal-title":"Journal of Clinical Oncology"},{"issue":"1","key":"10.1016\/bs.acr.2021.07.007_bb0910","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1542\/peds.2007-3204","article-title":"Neurofibromatosis type 1 revisited","volume":"123","author":"Williams","year":"2009","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/bs.acr.2021.07.007_bb0915","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/humu.20493","article-title":"Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5' splice-site disruption","volume":"28","author":"Wimmer","year":"2007","journal-title":"Human Mutation"},{"issue":"3","key":"10.1016\/bs.acr.2021.07.007_bb0920","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/gcc.20289","article-title":"Spectrum of single- and multiexon NF1 copy number changes in a cohort of 1,100 unselected NF1 patients","volume":"45","author":"Wimmer","year":"2006","journal-title":"Genes, Chromosomes & Cancer"},{"issue":"3","key":"10.1016\/bs.acr.2021.07.007_bb0925","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1399-0004.1986.tb00587.x","article-title":"Growth curves for height in Noonan syndrome","volume":"30","author":"Witt","year":"1986","journal-title":"Clinical Genetics"},{"issue":"19","key":"10.1016\/bs.acr.2021.07.007_bb0930","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1128\/MCB.00751-12","article-title":"Increased BRAF heterodimerization is the common pathogenic mechanism for noonan syndrome-associated RAF1 mutants","volume":"32","author":"Wu","year":"2012","journal-title":"Molecular and Cellular Biology"},{"issue":"8","key":"10.1016\/bs.acr.2021.07.007_bb0935","doi-asserted-by":"crossref","first-page":"630","DOI":"10.4161\/cbt.20080","article-title":"EphB4 promotes or suppresses Ras\/MEK\/ERK pathway in a context-dependent manner: Implications for EphB4 as a cancer target","volume":"13","author":"Xiao","year":"2012","journal-title":"Cancer Biology & Therapy"},{"issue":"4","key":"10.1016\/bs.acr.2021.07.007_bb0940","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(90)90149-9","article-title":"The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae","volume":"63","author":"Xu","year":"1990","journal-title":"Cell"},{"issue":"3","key":"10.1016\/bs.acr.2021.07.007_bb0945","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0092-8674(90)90024-9","article-title":"The neurofibromatosis type 1 gene encodes a protein related to GAP","volume":"62","author":"Xu","year":"1990","journal-title":"Cell"},{"issue":"1","key":"10.1016\/bs.acr.2021.07.007_bb0950","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/MED.0000000000000380","article-title":"Noonan syndrome: An update on growth and development","volume":"25","author":"Yart","year":"2018","journal-title":"Current Opinion in Endocrinology, Diabetes, and Obesity"},{"issue":"45","key":"10.1016\/bs.acr.2021.07.007_bb0955","first-page":"E10576","article-title":"SHOC2-MRAS-PP1 complex positively regulates RAF activity and contributes to Noonan syndrome pathogenesis","volume":"115","author":"Young","year":"2018","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"10.1016\/bs.acr.2021.07.007_bb0960","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/SLA.0b013e3181a77e9a","article-title":"Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome","volume":"249","author":"Zou","year":"2009","journal-title":"Annals of Surgery"}],"container-title":["Advances in Cancer Research","RAS: Past, Present, and Future"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065230X21000695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065230X21000695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T13:06:19Z","timestamp":1753362379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065230X21000695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9780128244852"],"references-count":192,"URL":"https:\/\/doi.org\/10.1016\/bs.acr.2021.07.007","relation":{},"ISSN":["0065-230X"],"issn-type":[{"value":"0065-230X","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]}}}